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Abstract
Background: The detection and quantification of uric acid in human physiological fluids is of great importance in
the diagnosis and therapy of patients suffering from a range of disorders associated with altered purine
metabolism, most notably gout and hyperuricaemia. The fabrication of cheap and reliable urate-selective
amperometric biosensors is a challenging task.
Results: A urate-selective microbial biosensor was developed using cells of the recombinant thermotolerant
methylotrophic yeast Hansenula polymorpha as biorecognition element. The construction of uricase (UOX)
producing yeast by over-expression of the uricase gene of H. polymorpha is described. Following a preliminary
screening of the transformants with increased UOX activity in permeabilized yeast cells the optimal cultivation
conditions for maximal UOX yield namely a 40-fold increase in UOX activity were determined.
The UOX producing cells were coupled to horseradish peroxidase and immobilized on graphite electrodes by
physical entrapment behind a dialysis membrane. A high urate selectivity with a detection limit of about 8 μM was
found.
Conclusion: A strain of H. polymorpha overproducing UOX was constructed. A cheap urate selective microbial
biosensor was developed.
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Background
Urate is the final purine intermediate of the purine
nucleotide catabolism in human [1]. Normally, urate is
not accumulated in human body fluids and hence its
concentration is a valuable indicator in clinical diagnosis
[2] indicating gout, hyperuricemia, or Lesch-Nyhan syn-
drome [3]. Elevated urate levels are also related to e.g.
increased alcohol and cholesterol consumption, obesity,
diabetes, kidney and heart diseases, and they are consid-
ered to be a risk factor for cardiovascular diseases [4].
Uricase (urate oxidase, UOX, EC 1.7.3.3) is a key
enzyme in the purine degradation pathway. It catalyzes
the oxidation of urate in the presence of oxygen, produ-
cing allantoin and CO2. Uricase does not require an
additional cofactor other than oxygen for the enzymatic
reaction and is therefore widely used for the ampero-
metric determination of urate to diagnose gout and the
above mentioned diseases and conditions. For urate
determination in serum and urine, several biosensors
have been reported [5-8]. Numerous amperometric
urate biosensors based on uricase or uricase coupled
with peroxidase varying in the type of electrode, immo-
bilization technique, ability and type of redox mediator
(s), conductive polymers etc. have been described [9-15].
Several new amperometric uric acid biosensors were
fabricated by immobilizing uricase onto gold nanoparti-
cles or carbon nanotubes [16-18]. These urate-selective
biosensors are using expensive commercially available
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globiformis,o rCandida utilis. Therefore, the fabrication
of cheap urate-selective amperometric biosensors is still
a challenging task.
In this work, we introduce a novel microbial urate-
selective amperometric biosensor based on the cells of
the uricase-overproducing recombinant yeast H.
polymorpha.
Results and Discussion
Construction of the uricase-overproducing recombinant
yeast H. polymorpha
Uricase-overproducing transformants of H. polymorpha
were constructed using straight-forward microbiological
techniques. The expression of target genes and corre-
sponding enzymatic activity in yeasts is increased by
repeated amplification of the required nucleotide
sequence [19,20]. The plasmid pGLG61 contains a bac-
terial APH gene (aminoglucoside-3-phosphotransferase)
as dominant marker whose expression is impaired, and
the sequence of the HARS36 (TEL188) autonomic repli-
cating sequence. This ensures multiple tandem integra-
tion of pGLG61 into the H. polymorpha telomere
regions on medium containing the antibiotic G418 [21].
The recombinant plasmid pGLG61_UOX (Figure 1A)
derived from pGLG61 was transformed to the recipient
strain H. polymorpha C-105 (gcr1, catХ), impaired in
glucose repression and devoid of catalase activity. The
transformants were grown on YPS medium in the pre-
sence of increasing concentrations of G418. The highest
concentration of G418 which allowed the transformants
to grow was 1 mg mL
-1. The transformants were stabi-
lized by cultivation in non-selective media for 10-12
generations with further shifting to the selective media
with G418. The presence of the expression cassette in
the stable transformants was examined by diagnostic
PCR using the primers Ko183/Ko190 and the genomic
DNA of stable transformants as a template. Fragments
o fp r e d i c t a b l es i z e( ~ 2 . 7k b )w e r eo b t a i n e d( d a t an o t
shown).
The parental strain С-105 exhibits impairment in glu-
cose catabolite repression of alcohol oxidase (AOX)
synthesis resulting in the induction of AOX in a glucose
containing growth medium [22]. Stable transformants
bearing UOX under control of the AOX promoter with
increased UOX enzyme activity were screened by a plate
patches assay in solid glucose-containing medium.
Finally, six positive recombinant strains (20, 22, 24, 28,
32, and 36) were selected (Figure 1B).
The UOX activity in cell-free extracts of the selected
strains was determined spectrophotometrically. As
shown in Figure 2A, the UOX activity of the selected
strains varied between 0.4 and 2.67 U mL
-1, while the
initial strain of H. polymorpha C-105 showed no signifi-
cant enzyme activity under the same growth conditions.
The C-105 cells were cultivated in urate containing
medium for induction of uricase. The UOX activity of
C-105 cultivated under inducing conditions was 0.067 U
mL
-1. Thus, the most active strain 22 showed a forty-
fold higher UOX activity as compared to the parental
strain.
The vector used for construction of UOX producers,
pGLG61_UOX, supports multiple tandem integration
into the telomeric chromosome region [21]. The uricase
gene copy number of strain 22 was established by quan-
titative Southern dot-blot via serial dilutions of the
genomic DNA and comparing to untransformed strain’s
single-copy signal of the H. polymorpha uricase gene.
The estimated vector copy number in transformants
which are resistant to 1 mg mL
-1 G418 was approxi-
mately 10 (Figure 3).
The dependence of UOX activity of strain 22 on the
growth phase is presented in Figure 2B. The maximal
level of UOX activity in cell-free extracts occurred after
Figure 1 A: Circular scheme of the plasmid pGLG61_UOX (8.5 kb). The HpAOX promoter and UOX ORF with terminator region are shown as
open boxes. The LEU2 gene H. polymorpha is shown as hatched box. Gene AmpR conferring resistance to ampicillin is shown as chequered
boxes. The H. polymorpha truncated glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter and the geneticin resistance gene (APH) are
shown as grey boxes, and the tellomeric region (TEL188) as black box. Restriction sites: B, BamHI; K, KpnI. B: Visualization of UOX activity in situ in
cells grown on mineral medium plates supplemented with glucose, incubated for 18 h, and then overlain with UOX reaction mixture with
permeabilizing agent as described in Materials and Methods section.
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-1 or 0.112 U mg
-1
DCW). This is in agreement with the dynamics of the
development of the AOX activity in C-105 strain during
cultivation in the same medium. As the yeast H. poly-
morpha belongs to the class of thermotolerant species
with highest growth temperature around 50°C [23], the
thermal stability of UOX was examined by incubating a
cell-free extract for 10 min at 50°C. Uricase lost about
32% of its activity and reached an activity of 2.3 U mL
-1
at 50°C. Obtained data is in accordance with the ther-
mal stability of uricase of C. utilis. Treatment at 50°C
caused about 60% of activity maximum in the crude
extract of the yeast [24].
The constructed overproducing strains exhibit signifi-
cantly lower UOX activity as compared with commer-
cially available recombinant UOX from Escherichia coli
or Saccharomyces cerevisiae [25,26]. However, their
genetic background makes the constructed strains a
unique ideal biorecognition element in microbial urate-
selective amperometric biosensors. The block in catalase
activity leads to the generation of H2O2 as a result of
urate oxidation that can be easily detected amperometri-
cally. A defect in the gene responsible for catalase synth-
esis forced the cells to develop a mechanism of H2O2
depletion through its extrusion from the cell [22,27].
H2O2 released from the cell facilitating its detection.
The impairment in glucose repression of the con-
structed strains allows for the overproduction of UOX
in a low-priced glucose-containing growth medium that
does not required expensive inducers, i.e. uric acid [28].
Evaluation and optimization of the urate biosensor
UOX catalyzes in vivo oxidation of uric acid in the pre-
sence of oxygen as an oxidizing agent producing allan-
toin and CO2 as oxidation products of uric acid and
hydrogen peroxide as a reduction product of O2.T h e
amperometric detection of uric acid can be performed
by electrochemical oxidation of the produced H2O2.
However, there is one serious problem which has to be
Figure 2 A: Specific UOX activity (U mL
-1) in cell-free extracts of the initial strain and the recombinant strains grown in mineral media
supplemented with 2% (wt/vol) glucose or 0.4% (wt/vol) urate; B: Time profile of UOX activity (U mL
-1 or U mg
-1 DCW) in cell-free
extracts of the recombinant strain 22 showing the dynamics of yeast growth in mineral medium supplemented with 2% (wt/vol)
glucose.
Figure 3 Southern dot-blot of genomic DNAs of strains
overproducing UOX probed with UOX ORF with terminator
region. Genomic DNAs of strains A–24 and C–22 with following
DNA dilution: 1– 1 μg without dilution; 2–twofold dilution; 3–5-fold
dilution; 4–10-fold dilution. B/1 and 4 – 1 μg of genomic DNA of
parental strain C-105 without dilution (one copy control). The
labeling of probe DNA and hybridization was performed using ECL
direct nucleic acid labeling and detection system.
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oxidized at Pt, Au and carbon electrodes at the poten-
tials necessary to oxidize H2O2 [29-31]. Amperometric
detection of H2O2 using horseradish peroxidase (HRP)
for its biocatalytic reduction to water has been proposed
[30,31].
A bienzyme system comprising UOX and one of a
hydrogen peroxide decomposing enzymes (HRP, catalase
(CAT) or microperoxidase (MP-11)) was evaluated for
the construction of urate-selective biosensors. The reac-
tion scheme and electron-transfer pathway is presented
in Figure 4.
Biosensor based on living cells of the uricase-overpro-
ducing recombinant strain of H. polymorpha coupled
with HRP exhibited the highest kinetic parameters I
max
=2 1 0n A ,K M = 0.47 mM for urate (Figure 5). Kinetic
parameters of sensors based on CAT or MP-11 were
quite similar (I
max = 137 or 135 nA, KM = 0.38 or 0.30
mM, respectively; Figure 5), however, due to the fact
that the HRP-based sensors showed the highest KM-
v a l u ea l lf u r t h e ri n v e s t i g a t i o n sw e r ed o n ew i t hH R P -
based sensors. This feature provides a wider range of
linearity thus improving the accuracy of the analysis by
reducing of the necessary sample dilutions. Moreover
t h er e s p o n s et i m ef o rt h es e n s o rb a s e do nH R P( 1 - 1 . 2
min) was shorter than that for CAT (1.2-1.4 min) or
MP-11 (1.5-1.8 min).
The immobilization of the strain 22 cells on graphite
disk electrodes was achieved by physical fixation behind
dialysis membranes. For further optimization, the ratio
of HRP to the cells and hence to UOX was varied. A
combination of 1 μLo fH R Ps o l u t i o na n d1μL of cell
suspension showed the highest current response (Figure
6). The increase in the HRP/cell ratio let to a decrease
of the current response apparently due to physical
blocking of the electrode surface with HRP. The
response time for the optimized sensor upon addition of
0.1 mM urate was about 5.5 nA min
-1. A typical current
response of a sensor with optimized architecture is
shown in Figure 7. The detection limit of the sensor
was determined to be 8 μM and the apparent KM value
obtained from several independent calibrations was 0.46
mM for urate. The optimal pH range for the urate bio-
sensor was 8.5 to 8.9, the optimal temperature range
was between 36 to 42°C (data not shown).
For application of the optimized prototype of the urate
sensor in real samples, its selectivity with respect to
potential interferences such as ascorbate, citrate, L-
Figure 5 Screening of the hydrogen peroxide decomposing
enzymes (MP-11, CAT or HRP). 3.05 mm graphite rod electrodes,
-50 mV vs. Ag/AgCl, 1 μL of each enzymes and 1 μL of cell
suspension. PDE and suspension of recombinant cells were
entrapped behind the dialysis membrane (cut off 10 kDa). Testing
solution: 30 mM Tris-HCl (pH 8.9); working volume: 20 mL; stock
solution of uric acid: 10 mM in 30 mM Tris-HCl (pH 8.9).
Figure 6 Evaluation of the optimal enzyme ratio (3.05 mm
graphite electrodes, -50 mV vs. Ag/AgCl).1μL HRP/1 μL of cell
suspension - (■), 1.5 μL HRP/1 μL of cell suspension - (●), 2 μL HRP/
1 μL of cell suspension - (▲). HRP and cell suspension were
entrapped behind the dialysis membrane (cut off 10 kDa). Testing
solution: 30 mM Tris-HCl (pH 8.9); working volume: 20 mL; stock
solution of uric acid: 10 mM in 30 mM Tris-HCl (pH 8.9).
Figure 4 Reaction scheme and electron-transfer pathway of
the proposed urate biosensor. PDE - hydrogen peroxide
decomposing enzymes (HRP, CAT or MP-11). PDE
ox and PDE
red -
oxidized and reduced forms of hydrogen peroxide decomposing
enzymes, UOX - urate oxidase.
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importance. Hence, the current response of the urate
biosensor was evaluated with respect to these substances
(Figure 8). The biosensor exhibits about 10% of cross-
sensitivity to ethanol and ascorbate relative to the urate
output level. However, no relative cross sensitivity to the
other investigated compounds was observed. As the
interfering compounds are present in significantly lower
concentrations e.g. in urine, the impact of these com-
pounds on the determination of urate in most real sam-
ples is assumed to be negligible.
The main characteristics of the developed urate
selective microbial biosensors are comparable with
previously reported results, such as an UOX-microper-
oxidase bi-enzyme system based on Au-electrode [13]
or a redox mediator (FcCOOH) containing UOX-HRP
system based on graphite electrode [12]. The detection
limit is higher (8 μMc o m p a r e dt o2μMo r0 . 6μMo f
urate), while the linear detection range is wider (180
μMv e r s u s7 5μMo r1 2 0μM of urate). The KM-values
[13] coincide with our results. At the same time the
estimated costs of the biosensor based on the urate
selective microbial cells appears to be significantly
reduced.
Conclusions
As t r a i no fH. polymorpha overproducing UOX was
constructed. Genomic integration of expression cassettes
o ft h eu r i c a s eg e n eu n d e rt h ec o n t r o lo ft h es t r o n gH.
polymorpha AOX promoter resulted in a 40-fold
increase in the UOX activity compared to the parental
strain. A method for preliminary screening of the
recombinant strains was developed. The conditions for
strain cultivation were optimized to ensure the maximal
amount of the target enzyme.
The strain identified as the one possessing highest
UOX activity was used for the construction of ampero-
metric urate biosensors. A urate-selective biorecognition
layer was designed comprising living cells of the recom-
binant H. polymorpha strain coupled to HRP. The term-
inal amperometric detection was achieved by direct
electron transfer between HRP and the graphite elec-
trode at -50 mV vs. Ag/AgCl. The sensor design was
optimized and a ratio of HRP/cells of 1:1 yielded the
highest current response. The detection limit of the
optimized sensor design was 8 μM and the apparent
KM-value 0.46 mM. Future research will be directed to
further increasing the UOX activity of H. polymorpha
and optimization of the electron-transfer cascade of the
described bi-enzyme system.
Figure 7 Left: Chronoamperometric current response upon subsequent additions of urate aliquots obtained with a microbial
biosensor entrapment behind a dialysis membrane; Right: urate calibration curve (-50 mV vs. Ag/AgCl). Testing solution: 30 mM Tris-HCl
(pH 8.9); working volume: 20 mL; stock solution of uric acid: 10 mM in 30 mM Tris-HCl (pH 8.9).
Figure 8 Selectivity of the optimized biosensor. Currents and
relative responses of different concentrations of D-glucose, ethanol,
urate, ascorbate, L-lactate, citrate and succinate are shown (-50 mV
vs. Ag/AgCl). HRP and cell suspension were entrapped behind the
dialysis membrane (cut off 10 kDa). Testing solution: 30 mM Tris-HCl
(pH 8.9); working volume: 20 mL; stock solution of D-glucose,
ethanol, urate, ascorbate, L-lactate, citrate and succinate: 10 mM in
30 mM Tris-HCl (pH 8.9). Sensor calibrations by possible urate
interfering compounds were performed on the same electrodes.
Urate calibration was performed after all measurements.
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Materials
Urate, L-lactic acid, horseradish peroxidase (HRP, EC
1.11.1.7), microperoxidase-11 (MP-11), 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC), catalase
(CAT, EC 1.11.1.6) and uricase (UOX, EC 1.7.3.3) were
obtained from Sigma. Succinic acid was from Fluka.
Citric acid monohydrate, ascorbic acid, D(+)-glucose
monohydrate were from J.T. Baker. Ethanol (abs.) was
from Riedel-de Haën and EDTA was from Serva; (NH4)
2SO4,N a 2HPO4,K H 2PO4,M g S O 4,C a C l 2 were obtained
from Merck. Dialysis membranes (cut off 10 kDa) were
from Biomol. All chemicals were of analytical grade and
all solutions were prepared using HPLC-grade water.
Solutions of glucose, ethanol, urate, L-lactic acid, ascor-
bic acid, succinic acid and citric acid were prepared in
30 mM Tris-HCl buffer, pH 8.9.
Strains, media, cultivation and preparation of microbial
cells
Cultivation of H. polymorpha CBS 4732 (leu2-2) [32],
C-105 (gcr1 catX) [22] and the recombinant producer
of uricase was performed in flasks on a shaker (200
rpm) at 37°C in a medium containing (g L
-1): (NH4)
2SO4 -3 . 5 ;K H 2PO4 -1 . 0 ;M g S O 4 ×7 H 2O - 0.5; CaCl2
- 0.1; yeast extract - 6. Glucose (20 g L
-1) was used as
carbon source. For induction of uricase, the cells from
the mid-exponential growth phase were washed once
in the mineral medium and transferred to shake-flask
cultures supplemented with 4 g L
-1 urate as carbon
source. Cultivation of the recombinant strain 22 was
performed for 64 h. To prevent degradation of target
enzyme, after washing, the cells were suspended in
30 mM Tris-HCl buffer (pH 8.9) containing 1 mM
phenylmethylsulfonyl fluoride (PMSF) and 1 mM ethy-
lenediaminetetraacetic acid (EDTA) followed by lyophi-
lization. Before experiments, the lyophilized yeast cells
were re-suspended to 30 mg mL
-1 dry cell weight
(DCW) in 30 mM Tris-HCl buffer, pH 8.9, containing
1m ME D T A .C e l l - f r e ee x t r a c t sw e r eo b t a i n e db yv o r -
texing with glass beads (425-600 μm; Sigma Cat No.
G-8772) followed by centrifugation as described pre-
viously [33].
The yeast C-105 (gcr1 catX)w a sg r o w no nY P S( 1 0g
L
-1 yeast extract, 20 g L
-1 peptone, and 20 g L
-1 sucrose)
at 37°C and used as a recipient strain for transformation
experiments. For the selection of yeast transformants on
YPS, 0.5-1.5 mg mL
-1 of the antibiotic geneticin (G418)
was added. The E. coli strain DH5a (F80dlacZΔM15,
recA1, endA1, gyrA96, thi-1, hsdR17(rK
-,m K
+), supE44,
relA1, deoR, Δ(lacZYA-argF)U169) was used as a host
for propagation of plasmids. The strain DH5a was
grown at 37°C in LB medium as described previously
[33]. Transformed E. coli cells were maintained on a
medium containing 100 mg L
-1 ampicillin.
Plasmid construction and molecular techniques
The H. polymorpha u r i c a s eg e n ew i t hat e r m i n a t o r
region (orf 201 hp_contig08, in the H. polymorpha gen-
ome database, Rhein Biotech) and the alcohol oxidase
gene promoter were amplified from the genomic DNA
of H. polymorpha strain CBS 4732 using the corre-
sponding pairs of primers: Ko189 5’-CAA TCT AAA
GTA CAA AAA CAA AGG TAC CAT GGC TGT
CCT GCA ATC GTC-3’ (KpnI)/Ko190 5’-CCG GGA
TCC TAC TCT TTG ATT GCC TCC-3’ (BamHI) and
Ko183 CGC GGA TCC TCG TTT AGA ACG TCC
TG-3’ (BamHI)/Ko188 5’-GAC GAT TGC AGG ACA
GCC ATG GTA CCT TTG TTT TTG TAC TTT AGA
TTG-3’ (KpnI). The primers Ko183 and Ko190 were
used to obtain a ~2.7 kb fragment containing the H.
polymorpha uricase gene with a terminator region dri-
ven by the alcohol oxidase gene promoter by overlap
PCR. This fragment was treated with restriction endo-
nuclease BamH Ia n dc l o n e di n t ot h eBamHI-linearized
and dephosphorylated plasmid pGLG61 [21], resulting
in the recombinant constructs pGLG61_UOX (Figure
1A).
Standard cloning techniques were applied [33]. PCR-
amplification of the fragments of interest was done with
Platinum
® Taq DNA Polymerase High Fidelity (Invitro-
gen) according to the manufacturer specification. PCR
was performed in a GeneAmp
® PCR System 9700 ther-
mocycler (Applied Biosystems). Transformation of the
yeast H. polymorpha by electroporation was carried out
as described previously [34]. Preparation of the total
DNA from yeast was carried out by using the DNeasy
®
Tissue Kit (Qiagen). Plasmid DNA isolations from E.
coli were performed by using NucleoSpin
® Plasmid
(Macherey-Nagel).
For quantitative Southern dot-blot, preparations of
serial dilutions of yeast genomic DNAs were denatured
in 0.4 M NaOH, spotted 2 μLp e rd o to n t od r yn y l o n
membrane (Hybond N+, Amersham Pharmacia Biotech).
The labeling of probe DNA and hybridization was per-
formed using non-radioactive ECL direct nucleic acid
labeling and detection system (Amersham Pharmacia
Biotech) according to the manufacturer’s manual.
Urate oxidase assay
The UOX activity in cell-free extracts was determined
spectrophotometrically by following the decrease of the
absorbance at 293 nm. Assay mixtures contained 0.1
mM urate in 0.1 M Tris-HC1 buffer (pH 8.9) [35]. The
reaction was started by the addition of the cell extract.
Enzyme assays were performed at 25°C. One unit was
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1 μmol of urate into allantoin in 1 min at 25°C and pH
8.9.
Strains with elevated UOX activity were screened by a
plate patch assay. UOX activity was visualized by the
rate of H2O2 formation. H2O2 is formed in the reaction
of UOX with urate and can be monitored by the peroxi-
dative oxidation of o-dianisidine in the presence of
horseradish peroxidase (HRP) leading to a purple col-
ouring of the patches. The transformants were patched
onto mineral medium agar plates supplemented with
glucose. After 18 h of incubation at 37°C, the plates
were overlaid with 9 mL of the UOX activity assay mix-
ture containing 0.1 M Tris-HC1 buffer (pH 8.9), 0.7%
(wt/vol) agar, digitonin (1 mg mL
-1), o-dianisidine (0.5
mg mL
-1), HRP Sigma RZ 1.1 (0.13 mg mL
-1), and urate
(0.1 mM). The plates were incubated at 37°C for up to 1
h. Patches that stained faster were selected for further
experiments. All assay experiments were repeated at
least twice.
Preparation and evaluation of the cell-based biosensors
Amperometric cell-based biosensors were evaluated
using constant-potential amperometry in a three-elec-
trode configuration with an Ag/AgCl/KCl (3 M) refer-
ence electrode and a Pt-wire counter electrode.
Amperometric measurements were carried out using a
bipotentiostat (EP 30, Biometra, Göttingen, Germany)
connected to a personal computer via a RS232 port for
data acquisition. Graphite rods (type RW001, 3.05 mm
diameter, Ringsdorff Werke, Bonn, Germany) were used
as working electrodes. They were sealed in glass tubes
by means of epoxy glue exposing a graphite disk. The
electrodes were polished on emery paper and ultrasoni-
cated in water.
HRP solution (300 U mL
-1) was dropped on the elec-
trode surface and dried at 4°C for 15 min. Alternative
CAT solution (400 U mL
-1) or MP-11 (0.05 mM) contain-
ing EDC (2.5 mM) were used. Amount of hydrogen perox-
ide decomposing enzymes was 1 μL, unless otherwise
stated. Then, 1 μL of the freshly prepared cells were
dropped on top of the hydrogen peroxide decomposing
enzymatic layer (HRP, CAT or MP-11) and dried at 4°C
for 15 min. Physical fixation was performed with a piece
of dialysis membrane and an O-ring. Before use, the elec-
trodes were rinsed with 30 mM Tris-HCl buffer, pH 8.9.
Defined amount of analyte was injected to measuring cell
after sensor stabilization (current baseline). The time of
the sensor-system stabilization was 9-10 min. The addi-
tional of the next urate concentration was performed for
the identical time periods (for approximately 5 min). The
electrodes were washed with distilled water between mea-
surements. Measurements were repeated at least three
times to ensure reproducibility. Between experiments, the
cell-modified electrodes were stored in buffer at 4°C.
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